Analyze Diet

Topic:Cholera

Cholera is an infectious disease caused by the bacterium Vibrio cholerae, primarily affecting the small intestine. While cholera is predominantly associated with humans, its potential impact on horses is an area of scientific inquiry. Research explores the susceptibility of horses to Vibrio cholerae, the mechanisms of transmission, and the clinical manifestations of the disease in equine populations. Studies also investigate the zoonotic potential of cholera and possible preventive measures in equine environments. This page compiles peer-reviewed research studies and scholarly articles that examine the epidemiology, pathophysiology, and management of cholera in horses.
The enhancement of the immune response against S. equi antigens through the intranasal administration of poly-epsilon-caprolactone-based nanoparticles.
Biomaterials    November 22, 2008   Volume 30, Issue 5 879-891 doi: 10.1016/j.biomaterials.2008.10.035
Florindo HF, Pandit S, Lacerda L, Gonçalves LM, Alpar HO, Almeida AJ.Strangles is a bacterial infection of the Equidae family that affects the nasopharynx and draining lymph nodes, caused by Streptococcus equi subspecies equi. This agent is responsible for 30% of all worldwide equine infections and is quite sensitive to penicillin and other antibiotics. However, prevention is still the best option because the current antibiotic therapy and vaccination is often ineffective. As S. equi induces very strong systemic and mucosal responses in convalescent horses, an effective and economic strangles vaccine is still a priority. In this study the humoral, cellular and ...
Mucosal co-administration of cholera toxin and influenza virus hemagglutinin-DNA in ponies generates a local IgA response.
Vaccine    June 12, 2003   Volume 21, Issue 21-22 3081-3092 doi: 10.1016/s0264-410x(03)00161-0
Soboll G, Nelson KM, Leuthner ES, Clark RJ, Drape R, Macklin MD, Swain WF, Olsen CW, Lunn DP.We have previously demonstrated that equine influenza virus hemagglutinin (HA) DNA vaccination protects ponies from challenge infection, and induces protective IgGa and IgGb responses. However, this approach does not induce a nasal IgA response. The objective of this study was to examine the value of cholera toxin (CT) administration as an adjuvant for intranasal HA DNA vaccination, and to measure protection 3 months after DNA vaccination. After an immunogenic dose of CT was determined, ponies were immunized on two occasions by intranasal administration of HA DNA and cholera toxin, or HA DNA a...
Nasal mucosal immunogenicity for the horse of a SeM peptide of Streptococcus equi genetically coupled to cholera toxin.
Vaccine    February 23, 2002   Volume 20, Issue 11-12 1653-1659 doi: 10.1016/s0264-410x(01)00488-1
Sheoran AS, Artiushin S, Timoney JF.The intranasal immunogenicity of cholera toxin (CT) genetically coupled to peptide sequence aa236-334 (F3) of the SeM protein of Streptococcus equi was studied in five young adult Welsh ponies. All ponies made rapid CTB- and SeMF3-specific serum antibody responses following the first immunization. Specific nasal IgA responses were detected in two ponies 14 days after the first immunization, in another two 14 days after a second immunization on day 14, and in all ponies 28 days after a third immunization on day 42. SeMF3-specific antibody responses in sera and nasal washes were dominated by IgG...
BERNA: a century of immunobiological innovation.
Vaccine    October 3, 1999   Volume 17 Suppl 2 S1-S5 doi: 10.1016/s0264-410x(99)00228-5
Cryz SJ.At the time the Swiss Serum and Vaccine Institute Berne (BERNA) was found in 1898, few vaccines or immune globulins were available. This short list included vaccines against cholera, typhoid fever, plague, smallpox and rabies and equine anti-tetanus and diphtheria immune globulins. Furthermore, their use was restricted due to limited production capacity, uncertainty regarding safety and no public health infrastructure to promote their utilization. Today, safe and effective vaccines exist for more than 30 infectious diseases while human hyperimmune globulins exist to treat or prevent rabies, te...
Activation of pigeon erythrocyte adenylate cyclase by cholera toxin. Partial purification of an essential macromolecular factor from horse erythrocyte cytosol.
Biochimica et biophysica acta    February 5, 1981   Volume 672, Issue 3 248-261 doi: 10.1016/0304-4165(81)90291-9
Le Vine H, Cuatrecasas P.A cytosolic, macromolecular factor required for the cholera toxin-dependent activation of pigeon erythrocyte adenylate cyclase and cholera toxin-dependent ADP-ribosylation of a membrane-bound 43,000 dalton polypeptide has been purified 1100-fold from horse erythrocyte cytosol using organic solvent precipitation and heat treatment. This factor, 13,000 daltons, does not absorb to anionic or cationic exchange resins, is sensitive to trypsin or 10% trichloroacetic acid and is not extractable by diethyl ether. Activation of adenylate cyclase by cholera toxin requires the simultaneous presence of AT...
The comparative studies on the immune reactions of anti-cholera horse and rabbit serum.
The Japanese journal of experimental medicine    August 1, 1953   Volume 23, Issue 4 305-311 
IIDA T.No abstract available